Frequency of undiagnosed HIV infection in patients of seborrheic dermatitis

Dr. Zaib, Khalida Ahtesham, Tahira Tabassum, Anam Ilyas, Sara Inayat, Zaeem Sohail Jafer, Ahmad Amin Khan Fraz

Abstract


Introduction  The incidence of human immunodeficiency virus (HIV) infection, is increasing in Pakistan. Seborrheic dermatitis (SD) can be seen in patients having HIV infection, so it can be a marker of disease diagnosis and progression.

 

Objective To see the occurrence of HIV infection in patients with SD.

 

Methods A prospective study was conducted in Dermatology Department, DHQ teaching hospital, University Medical Complex and Research Center, Sargodha, from September, 2019-February, 2020. Two hundred and eighty-five cases of SD diagnosed clinically were taken and serological examination for HIV by rapid diagnostic test was done on all cases. Data analysis were done by Statistical Package for the Social Sciences (SPSS) Version 20 and expressed as frequency and percentage.

 

Results  In 285 cases of SD majority (53.6%) were males. Ages of patients ranged from 8 months to 60 years. Out of the 31 patients positive for HIV, 25 were males and rest were females. Majority of HIV positive cases (70.96%) had severe SD.

 

Conclusion  SD is a dermatological manifestation of HIV infection. As in developing countries like Pakistan with limited health facilities it is difficult to have CD4+ counts done, skin examination should be an important tool for assessing immune status and management of HIV positive patients.

 


Keywords


Human immunodeficiency virus (HIV); seborrheic dermatitis (SD); CD4 count; dermatological manifestation; immune status

Full Text:

PDF

References


Azfar NA, Khan AR, Zia MA, Humayun A, Malik LM, Jahangir M. Frequency of mucocutaneous manifestations in HIV positive Pakistani patients. J Pak Associa Dermatol. 2011;21(3): 149-53.

Cholette F, Joy J, Pelcat Y, Thompson LH, Pilon R, Ho J, et al. HIV-1 phylodynamic analysis among people who inject drugs in Pakistan correlates with trends in illicit opioid trade. PLoS ONE 2020;15(8): e0237560.

Lucas S, Nelson AM. HIV and the spectrum of human disease. J Pathol. 2015;235: 229–41.

Neeti K, Kewal K, Bela B, Gunjan G, Bist J S, Kumar MA. Study of cutaneous manifestations in HIV infection. IAIM. 2017;4(12): 99-106.

Cedeno-Laurent F, Gómez-Flores M, Mendez N , Ancer-Rodríguez J, Bryant JL, Gaspari AA et al. New insights into HIV-1-primary skin disorders. JIAS (Serial online) 2011. Available online at: https://doi.org/10.1186/1758-2652-14-5 (Last accessed in October, 2020)

Nnoruka EN, Chukwuka JC, Anisuiba B. Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression. Int J Dermatol. 2007;46:14-18.

Kore SD, Kanwar AJ, Vinay K, Wanchu A. Pattern of mucocutaneous manifestations in human immunodeficiency virus-positive patients in North India. Indian J Sex Transm Dis 2013;34:19-24.

Garg T, Sanke S. Inflammatory dermatoses in human immunodeficiency virus. Indian J Sex Transm Dis AIDS. 2017;38(2):113-20.

Araya M, Kulthanan K, Jiamton S. Clinical characteristics and quality of life of seborrheic dermatitis patients in a tropical country. Indian J Dermatol. 2015;60(5):519.

Moreno-Coutino˜ G, Sánchez-Cárdenas CD, Bello-Hernández Y, Fernández-Martínez R, Arroyo-Escalante S, Arenas R. Isolation of Malassezia spp. in HIV-positive patients with and without seborrheic dermatitis. An Bras Dermatol. 2019;94(5): 527-31.

Forrestel AK, Kovarik CL, Mosam A, et al. Diffuse HIV-associated seborrheic dermatitis - a case series. Int J STD & AIDS. 2016;27(14):1342-5.

Mourez T, Lemée V, Delbos V, et al. HIV rapid screening tests and self-tests: Be aware of differences in performance and cautious of vendors. EBioMedicine. 2018;37: 382-91.

Borda LJ, Perper M, Keri JE. Treatment of seborrheic dermatitis: a comprehensive review. J Dermatol Treat. 2019;30(2): 158-69.

Amado Y, Patiño-Uzcátegui A, Cepero de García MC, Tabima J, Motta A, Cárdenas M, et al. Seborrheic dermatitis: predisposing factors and ITS2 secondary structure for Malassezia phylogenic analysis. Med Mycol. 2013;51(8): 868–75.

Sanders MGH, Pardo LM, Franco OH, Ginger RS, Nijsten T. Prevalence and determinants of seborrhoeic dermatitis in a middle-aged and elderly population: the Rotterdam Study. Br J Dermatol. 2018;178(1):148-53.

Emre S, Kalkan G, Erdoǧan S, Akta A, Ergin M. Dynamic thiol/disulfide balance in patients with seborrheic dermatitis: A case–control study. Saudi J Med Med Sci. 2020;8:12-6

Del Rosso JQ. Adult seborrheic dermatitis: a status report on practical topical management. J Clin Aesthet Dermatol. 2011;4(5):32-8.

Ippolito F, Passi S, Di Carlo A. Is seborrhoeic dermatitis a clinical marker of HIV disease? Minerva Ginecol. 2000; 52(12):54-8.


Refbacks

  • There are currently no refbacks.


ISSN: 1560-9014